Sanaria featured in BBC News story, A Faster Path to a Possible Malaria Vaccine
Malaria kills more than 650,000 people every year and scientists say they are close to finding a vaccine, but the method of testing for a vaccine has long been time-consuming and risky to transport.
Now Sanaria, a biotechnology firm based in the US state of Maryland, has developed the first injectable form of malaria, speeding up clinical trials, reducing the time it could take to develop a vaccine and helping researchers more easily share their work.
